PD-1 mAb
/ AbelZeta Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 09, 2023
C-TIL051 in Non-Small Cell Lung Cancer
(clinicaltrials.gov)
- P1 | N=20 | Not yet recruiting | Sponsor: Cellular Biomedicine Group, Inc.
Metastases • New P1 trial • Lung Adenocarcinoma • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1